IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 275 filers reported holding IMMUNOGEN INC in Q3 2023. The put-call ratio across all filers is 0.37 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,297,532 | +638.8% | 144,772 | +122.2% | 1.06% | +497.2% |
| Q3 2022 | $311,000 | -64.0% | 65,151 | -66.0% | 0.18% | -65.8% |
| Q2 2022 | $863,000 | +133.2% | 191,726 | +146.8% | 0.52% | +121.7% |
| Q1 2022 | $370,000 | +170.1% | 77,694 | +222.5% | 0.24% | +158.2% |
| Q3 2021 | $137,000 | +38.4% | 24,088 | +61.4% | 0.09% | +30.0% |
| Q2 2021 | $99,000 | -18.2% | 14,929 | 0.0% | 0.07% | -22.2% |
| Q1 2021 | $121,000 | -15.4% | 14,929 | -32.4% | 0.09% | -1.1% |
| Q4 2020 | $143,000 | +49.0% | 22,100 | -17.5% | 0.09% | +30.0% |
| Q3 2020 | $96,000 | – | 26,800 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SILVERARC CAPITAL MANAGEMENT, LLC | 600,000 | $3,870,000 | 2.25% |
| CM Management, LLC | 375,000 | $2,419,000 | 2.24% |
| Consonance Capital Management LP | 3,515,944 | $22,678,000 | 2.12% |
| RA Capital Management | 18,417,458 | $118,793,000 | 1.66% |
| Kercheville Advisors, LLC | 244,421 | $1,564,000 | 0.85% |
| Redmile Group, LLC | 10,528,179 | $67,907,000 | 0.82% |
| Birchview Capital, LP | 190,000 | $1,226,000 | 0.71% |
| QVT Financial LP | 1,375,900 | $8,875,000 | 0.49% |
| Fernwood Investment Management, LLC | 149,340 | $963,000 | 0.38% |
| TWIN FOCUS CAPITAL PARTNERS, LLC | 104,068 | $671,000 | 0.21% |